We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Unlocking Insights for Underrepresented Patients: The Role of Real-World Evidence in Addressing Limitations of CDK4/6 Inhibitor RCTs
Adam Brufsky, MD, PhD
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
Christopher M. Gallagher, MD
Real World Use of RWE in HR+ Metastatic Breast Cancer: The Oncologist Perspective
Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects
Insomnia Treatment Goals: Restful Nights and Productive Days
Kevin Trice, MD
Michael E. Yurcheshen, MD, FAASM
Sleep Architecture and Neurotransmitters of Sleep
Patient Perspective: Living With Insomnia
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
Utilizing Assessment Tools in Insomnia
Examining Treatment Options for Insomnia: From Orexin to GABA
Integrating Evidence and Cultural Sensitivity in Patient-Centric Insomnia Treatments
Resectable Melanoma: New & Emerging Adjuvant Treatments
Nikhil I. Khushalani, MD
Tara C. Mitchell, MD
Which Resected Stage II Melanoma Patients Benefit from Adjuvant ICI Therapy?
Adjuvant Treatment for BRAF+ Stage III Melanoma: A Case Study to Weigh ICI Versus Targeted Therapies
Optimizing Adjuvant Treatment for Stage IV Melanoma Patients Rendered NED After Surgery
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education